PROVENTION BIO INC
PROVENTION BIO INC
Action · US74374N1028 · PRVB · A2JRLW (XNAS)
Aperçu Indicateurs financiers
Pas de cours
n/a

Performance

Jour Semaine Mois 3 mois 6 mois 1 an 5 ans
- - - - 0,00 % 0,00 % 104,92 %

Profil de l'entreprise pour PROVENTION BIO INC Action

Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one diabetes (T1D); PRV-3279, which has completed Phase Ib clinical trial for the treatment of lupus; PRV-101, a coxsackie virus B (CVB) vaccine for the prevention of acute CVB infections and onset of T1D; and PRV-015, which is in phase IIb clinical trial for the treatment of gluten-free diet non-responding celiac disease. The company has a license and collaboration agreement with Amgen Inc. for PRV-015, a novel anti-IL-15 monoclonal antibody being developed for the treatment of gluten-free diet non-responsive celiac disease; and a strategic collaboration with Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. to develop and commercialize PRV-3279, a bispecific antibody-based molecule targeting the B cell surface proteins CD32B and CD79B in Greater China. Provention Bio, Inc. was incorporated in 2016 and is headquartered in Red Bank, New Jersey.

Fonds investis

Les fonds suivants ont investi dans : PROVENTION BIO INC investi :

Fonds
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. en millions
13,76
Part (%)
0,03 %

Données de l'entreprise

Nom PROVENTION BIO INC
Société Provention Bio, Inc.
Symbole PRVB
Site web https://www.proventionbio.com
Marché d'origine XNAS NASDAQ
WKN A2JRLW
ISIN US74374N1028
Type de titre Action
Secteur Healthcare
Industrie Biotechnology
PDG Mr. Ashleigh W. Palmer B.Sc., M.B.A.
Capitalisation boursière 2 Mrd.
Pays États-Unis d'Amérique
Devise USD
Employés 0,2 T
Adresse 55 Broad Street, 07701 Red Bank
Date d'introduction en bourse 2018-07-24

Symboles boursiers

Nom Symbole
NASDAQ PRVB

Autres actions

Les investisseurs qui détiennent PROVENTION BIO INC ont également les actions suivantes dans leur portefeuille :
AMGEN INC
AMGEN INC Action
AUTODESK INC
AUTODESK INC Action
AUTOMATIC DATA PROCESSING INC
AUTOMATIC DATA PROCESSING INC Action
CISCO SYSTEMS INC
CISCO SYSTEMS INC Action
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Action
DEGI EUROPA
DEGI EUROPA Fonds
HONEYWELL INTERNATIONAL INC
HONEYWELL INTERNATIONAL INC Action
INTEL CORP
INTEL CORP Action
LB.HESS.THR.CA.TIL.11B/18
LB.HESS.THR.CA.TIL.11B/18 Obligation
MICROSOFT CORP
MICROSOFT CORP Action
QIAGEN NV (alt)
QIAGEN NV (alt) Action
SAUDI ARAMCO 20/70 MTN
SAUDI ARAMCO 20/70 MTN Obligation
TWIN DISC INCPORATED
TWIN DISC INCPORATED Action
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Action
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles. Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Mentions légales Protection des données Blog Communauté Retour d'information Changelog
Im App Store herunterladen Bei Google Play herunterladen
Tous droits réservés © LCP GmbH 2025